FacebookeXperts Weigh in on FBXW7-AS1 (DEAR), a Potential Drug Target and Biomarker

Target Name: FBXW7-AS1

NCBI ID: G102191832

FBXW7-AS1

Other Name(s): DEAR | FBXW7 antisense RNA 1 | DEspR

FacebookeXperts Weigh in on FBXW7-AS1 (DEAR), a Potential Drug Target and Biomarker

The identification and characterization of potential drug targets and biomarkers is a critical aspect of drug development. These targets and biomarkers can provide valuable information about the underlying disease and the efficacy of a drug. In this article, we will discuss FBXW7-AS1 (DEAR), a potential drug target and biomarker.

FBXW7-AS1 (DEAR) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the FERMT3 family, which is known for its role in cell-type specificity and cytoskeletal organization. FBXW7-AS1 (DEAR) has been shown to play a role in the regulation of neural cell survival and proliferation, which is important for the development and progression of various neurological disorders.

One of the key functions of FBXW7-AS1 (DEAR) is its role in the regulation of mitochondrial function. Mitochondria are organelles that are responsible for generating energy for the cell through a process called cellular respiration. FBXW7-AS1 (DEAR) has been shown to play a role in the regulation of mitochondrial fusion, which is the process by which new mitochondria are formed in the cell.

In addition to its role in mitochondrial function, FBXW7-AS1 (DEAR) has also been shown to play a role in the regulation of cellular signaling pathways. It is a positive regulator of the protein p21, which is a well-known tumor suppressor protein. p21 is involved in the regulation of cell cycle progression, and FBXW7-AS1 (DEAR) has been shown to promote the expression of p21 in cancer cells.

Another function of FBXW7-AS1 (DEAR) is its role in the regulation of cellular adhesion. Adhesion is the process by which cells stick together to form tissues and organs. FBXW7-AS1 (DEAR) is involved in the regulation of cell-cell adhesion, which is important for the development and maintenance of tissues and organs.

FBXW7-AS1 (DEAR) has also been shown to play a role in the regulation of neural networks. Neural networks are complex systems that are responsible for processing and transmitting information in the brain. FBXW7-AS1 (DEAR) is involved in the regulation of the formation and function of neural networks, which is important for the development and progression of various neurological disorders.

In conclusion, FBXW7-AS1 (DEAR) is a protein that has been shown to play a role in the regulation of various cellular processes that are important for the development and progression of various neurological disorders. The potential drug target and biomarker that FBXW7-AS1 (DEAR) represents makes it an attractive target for drug development in the field of neurological disorders. Further research is needed to fully understand the role of FBXW7-AS1 (DEAR) in the regulation of neural cells and its potential as a drug target.

Protein Name: FBXW7 Antisense RNA 1

Functions: Dual endothelin-1/angiotensin-2 receptor that is functionally coupled to a calcium-mobilizing transduction system, responding equivalently to both endothelin-1/EDN1 and angiotensin-2 peptides in a highly specific manner (PubMed:17446437, PubMed:24465725). Also binds the signal peptide of VEGFA (PubMed:17446437, PubMed:24465725). May play a role in angiogenesis with a significant role in cardiovascular and neural development (By similarity)

The "FBXW7-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FBXW7-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets